Is BA a buy, hold, or sell?
BA carries a valuation grade of Reduce. The trailing P/E of 88.0 sits 300% above the Industrials sector median of 22.0x — a premium that demands sustained earnings delivery. Our discounted cash flow model produces an intrinsic range of $184–$244 — implying a -4% margin of safety at the current price of $222.72. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 9% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 70.3% earnings surprise. Analyst estimate revisions are trending upward.
What are BA's key risk factors?
With a beta of 1.20, BA exhibits an above-market risk profile relative to the broad market. The 95th-percentile CVaR of -18.5% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 1.8% of total portfolio loss in the worst 5% of months. Net margins of 2.5% fall below the Industrials sector average of 11%, suggesting margin pressure. Return on equity of 169.9% indicates highly efficient capital allocation. Debt-to-equity of 829% warrants monitoring for leverage risk.
At 0.78, the put/call ratio skews bullish, with call buyers dominating recent flow. Implied and realized volatility are roughly aligned at 36.6% and 40.2% respectively. Insiders have been net sellers to the tune of $11.1M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 0.1% of float, suggesting limited bearish conviction.
How does BA fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — BA carries a beta of 1.20, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all reduceings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, BA shows the strongest co-movement with GS (0.33), AMZN (0.28), CAT (0.22). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all reduceings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The BA analysis here is a single node in that larger structure.
For the full transatlantic conviction hierarchy — including BA's position sizing, conviction rating, and upside/risk case in the 2026 defence supercycle — see: Defence Spending 2026: The Transatlantic Allocation Case →
